ATE369132T1 - Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften - Google Patents
Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaftenInfo
- Publication number
- ATE369132T1 ATE369132T1 AT03776442T AT03776442T ATE369132T1 AT E369132 T1 ATE369132 T1 AT E369132T1 AT 03776442 T AT03776442 T AT 03776442T AT 03776442 T AT03776442 T AT 03776442T AT E369132 T1 ATE369132 T1 AT E369132T1
- Authority
- AT
- Austria
- Prior art keywords
- potassium salt
- flow properties
- losartan potassium
- improved flow
- producing
- Prior art date
Links
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical class [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002083 C09CA01 - Losartan Substances 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000519 losartan potassium Drugs 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41945002P | 2002-10-17 | 2002-10-17 | |
| US42607202P | 2002-11-12 | 2002-11-12 | |
| US42646102P | 2002-11-14 | 2002-11-14 | |
| US43145002P | 2002-12-04 | 2002-12-04 | |
| US43180902P | 2002-12-09 | 2002-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE369132T1 true ATE369132T1 (de) | 2007-08-15 |
Family
ID=32111134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03776442T ATE369132T1 (de) | 2002-10-17 | 2003-10-17 | Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040171843A1 (de) |
| EP (1) | EP1471908B1 (de) |
| AT (1) | ATE369132T1 (de) |
| AU (1) | AU2003284262A1 (de) |
| DE (1) | DE60315417T2 (de) |
| ES (1) | ES2290518T3 (de) |
| WO (1) | WO2004035049A1 (de) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE214388T1 (de) * | 1996-10-29 | 2002-03-15 | Merck & Co Inc | Verfahren zur kristallisation von losartan |
| ES2234451T1 (es) * | 2001-11-14 | 2005-07-01 | Teva Pharmaceutical Industries Ltd. | Formas cristalinas y amorfas de losartan potasio y procedimiento para su preparacion. |
-
2003
- 2003-10-17 EP EP03776442A patent/EP1471908B1/de not_active Expired - Lifetime
- 2003-10-17 AT AT03776442T patent/ATE369132T1/de not_active IP Right Cessation
- 2003-10-17 WO PCT/US2003/032885 patent/WO2004035049A1/en not_active Ceased
- 2003-10-17 ES ES03776442T patent/ES2290518T3/es not_active Expired - Lifetime
- 2003-10-17 AU AU2003284262A patent/AU2003284262A1/en not_active Abandoned
- 2003-10-17 DE DE60315417T patent/DE60315417T2/de not_active Expired - Fee Related
- 2003-10-17 US US10/688,697 patent/US20040171843A1/en not_active Abandoned
-
2006
- 2006-04-13 US US11/404,368 patent/US20060241161A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1471908B1 (de) | 2007-08-08 |
| DE60315417T2 (de) | 2008-04-30 |
| DE60315417D1 (de) | 2007-09-20 |
| EP1471908A1 (de) | 2004-11-03 |
| US20040171843A1 (en) | 2004-09-02 |
| AU2003284262A8 (en) | 2004-05-04 |
| ES2290518T3 (es) | 2008-02-16 |
| US20060241161A1 (en) | 2006-10-26 |
| WO2004035049A1 (en) | 2004-04-29 |
| AU2003284262A1 (en) | 2004-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE502004009142D1 (de) | Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen | |
| ATE501182T1 (de) | Verfahren zur herstellung eines olefinpolymerisationskatalysators | |
| DE60325188D1 (de) | Verfahren zur herstellung von sterilen, stabilisierten nanodispersionen | |
| DE502006001309D1 (de) | Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung | |
| DE602004004615D1 (de) | Verfahren zur Herstellung von Fluoropolymerdispersionen | |
| DE50304622D1 (de) | Verfahren zur Herstellung einer elastischen, luftdurchlässigen Verbundfolie | |
| ATE506356T1 (de) | Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen | |
| DE602004031907D1 (de) | Verfahren zur Herstellung von Nanopartikeln durch grössenspezifische Photoätzung | |
| DE602004020895D1 (de) | Verfahren zur herstellung von kohlenstoffnanospulen | |
| DE502005001841D1 (de) | Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten | |
| DE602004002651D1 (de) | Verfahren zur Herstellung einer Vinylverbindung. | |
| DE60322763D1 (de) | Verfahren zur Herstellung eines Pulvers mit hohem Gerbstoffgehalt | |
| DE502005000428D1 (de) | Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen | |
| ATE391115T1 (de) | Verfahren zur herstellung von diketenacetalen | |
| ATE275149T1 (de) | Verfahren zur herstellung von taxanderivaten | |
| ATE372970T1 (de) | Verfahren zur herstellung von 3,5- bis(trifluormethyl)benzylalkohol | |
| DE602005011814D1 (de) | Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten | |
| ATE374757T1 (de) | Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten | |
| ATE369132T1 (de) | Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften | |
| DE502006002680D1 (de) | Verfahren zur herstellung von feinteiligem c.i. pigment red 254 | |
| ATE501104T1 (de) | Verfahren zur herstellung von 1,2,2,2-tetrafluor- ethyl-difluor-methylether | |
| ATE515502T1 (de) | Verfahren zur herstellung von tetranorlabdanderivaten | |
| EP1270564A4 (de) | Verfahren zur herstellung von 3-fluoroalkoxymethyl-3-alkyloxetanen | |
| ATE464289T1 (de) | Neues verfahren zur herstellung von thoc | |
| ATE395334T1 (de) | Verfahren zur herstellung von (3-oxo-2,3-dihydro- 1h-isoindol-1-yl)-acetylguanidin-derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |